| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |